digestVidSign in
summary

Leonid Kim MD - Should You Take MILK THISTLE for Your Liver Health? An Evidence-based Review

Thumbnail of the video “Leonid Kim MD - Should You Take MILK THISTLE for Your Liver Health? An Evidence-based Review”
Community upload. AI output has not been independently verified.
Author: Leonid Kim MD
Categories: Health
Tags: health
Views: 2 · Last viewed: 2026-10-16 15:02 UTC

Short Summary

Main recommendation: Dr. Leonid Kim does not routinely recommend milk thistle (silymarin) for fatty liver or other liver diseases, because the human evidence is too limited, though he would not tell most patients to stop it unless there is a medication interaction concern. Milk thistle showed a modest benefit in mild liver disease and early fatty liver disease, with little evidence of benefit in advanced stages such as NASH or cirrhosis.

Key Points

  • Milk thistle's active ingredient is silymarin, extracted from the seeds and fruits of the Silybum marianum plant, and it has been used medically in Europe for centuries.
  • The 2001 pooled analysis of five studies reported liver-related mortality of 4.9% per year with silymarin versus 9.3% per year with placebo.
  • A Cochrane review of 18 randomized trials found a reduction in liver-related mortality only when lower-quality trials were included, not in high-quality trials, so larger studies are needed.
  • Silymarin consistently reduced liver enzymes (ALT, AST) compared with placebo, and small studies showed improvements in abdominal circumference, BMI, and ultrasound findings in non-alcoholic fatty liver disease.
  • In a 48-week NASH trial at 2100 mg per day, silymarin significantly reduced fibrosis but did not meet its primary endpoint of a 30% improvement in the NAFLD Activity Score.

Details Worth Noting

  • Concrete instructions: The video gives no step-by-step protocol for taking milk thistle. It only cites study doses: 600 mg per day for 12 months in alcoholic cirrhosis with diabetes, 2100 mg per day for 48 weeks in NASH, and up to 420 mg per day for up to four years in clinical trials. Speaker advice: talk to your doctor before taking this or any supplement to confirm it is safe for your situation, and check for interactions with other medications.
  • Study context: the four-week trial of 97 patients with mild alcohol-related liver disease showed significantly greater liver function improvement with silymarin than placebo.
  • Diabetes data: the 12-month study of 60 people with alcoholic cirrhosis and diabetes found reduced hemoglobin A1c and exogenous insulin requirements at 600 mg per day.
  • Safety: adverse events were minor, mostly headaches, diarrhea, and nausea, and the video notes tolerability at the doses above.
  • Limitation: Dr. Kim notes that many studies with no mortality benefit included patients with severe, end-stage irreversible liver disease, which may have masked an effect.

Bottom Line

Milk thistle may offer a small benefit in mild or early liver disease and appears relatively safe, but the video's speaker does not view the current evidence as strong enough to routinely recommend it for fatty liver or other liver conditions.